(BSCS) Invesco BulletShares 2028 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138J6432

BSCS: Corporate Bonds, Investment Grade, Target Maturity

The Invesco BulletShares 2028 Corporate Bond ETF is a targeted maturity ETF that focuses on investment-grade corporate bonds maturing in 2028, providing a defined maturity date and potentially reducing interest rate risk.

By tracking a specific index, the fund ensures a high level of transparency and predictability in its holdings, allowing investors to better understand the underlying securities and associated risks. The funds investment strategy is centered around U.S. dollar-denominated corporate bonds, which can provide a relatively stable source of returns in a diversified portfolio.

Given the current market conditions and the funds technical indicators, such as the SMA20, SMA50, and SMA200, it appears that the ETF is trending upwards, with the short-term moving averages above the long-term average, indicating a potential bullish signal. The ATR of 0.05, or 0.23%, suggests relatively low volatility, which is consistent with the characteristics of investment-grade corporate bonds.

Using the available technical and fundamental data, a forecast for the BSCS ETF could be constructed. With the current AUM of $2604.72M USD and the relatively stable price action, it is possible that the ETF will continue to attract investors seeking exposure to high-quality corporate bonds with a defined maturity date. Assuming interest rates remain stable or decrease, the demand for such bonds may increase, potentially driving the price of the ETF higher. A potential price target could be around $20.80, representing a 2% increase from the current price, based on the historical volatility and the current trend.

It is essential to note that this forecast is based on the available data and should be continuously monitored and updated as new information becomes available. The actual performance of the ETF may differ from the forecast due to various market and economic factors.

Additional Sources for BSCS ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BSCS ETF Overview

Market Cap in USD 2,618m
Category Target Maturity
TER 0.10%
IPO / Inception 2018-08-09

BSCS ETF Ratings

Growth Rating 18.0
Fundamental -
Dividend Rating 71.7
Rel. Strength -6.26
Analysts -
Fair Price Momentum 20.09 USD
Fair Price DCF -

BSCS Dividends

Dividend Yield 12m 4.59%
Yield on Cost 5y 4.79%
Annual Growth 5y 7.39%
Payout Consistency 95.0%
Payout Ratio %

BSCS Growth Ratios

Growth Correlation 3m 90.4%
Growth Correlation 12m 86.9%
Growth Correlation 5y -9.3%
CAGR 5y 1.17%
CAGR/Max DD 5y 0.07
Sharpe Ratio 12m 2.68
Alpha 3.02
Beta 0.006
Volatility 2.94%
Current Volume 355.4k
Average Volume 20d 382.7k
What is the price of BSCS shares?
As of June 29, 2025, the stock is trading at USD 20.46 with a total of 355,422 shares traded.
Over the past week, the price has changed by +0.43%, over one month by +0.92%, over three months by +1.95% and over the past year by +7.28%.
Is Invesco BulletShares 2028 a good stock to buy?
Neither. Based on ValueRay´s Analyses, Invesco BulletShares 2028 is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 17.98 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BSCS is around 20.09 USD . This means that BSCS is currently overvalued and has a potential downside of -1.81%.
Is BSCS a buy, sell or hold?
Invesco BulletShares 2028 has no consensus analysts rating.
What are the forecasts for BSCS share price target?
According to our own proprietary Forecast Model, BSCS Invesco BulletShares 2028 will be worth about 21.7 in June 2026. The stock is currently trading at 20.46. This means that the stock has a potential upside of +6.01%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.7 6%